ANGLE plc (GB:AGL) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
ANGLE plc has unveiled promising new data at the AACR Special Conference, highlighting its Parsortix-based PD-L1 assay’s potential in improving personalized treatment for lung cancer patients. This innovative liquid biopsy technology enables non-invasive, ongoing monitoring of PD-L1 status in circulating tumor cells, which could offer a more dynamic and comprehensive assessment of tumor heterogeneity compared to traditional tissue biopsies.
For further insights into GB:AGL stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue